(PAR) Par Drugs complete technical analysis [charts+indicators] | Buy/Sell Par Drugs | (PAR) share price targets
Complete technical analysis of Par Drugs (PAR) by charts plus indicators, forecast predictions and share price targets for Par Drugs (PAR)
Showing technical analysis as on 2024-09-18 View latest technical analysis
10 day averaged volume of Par Drugs is 55629
Date | Daily Closing Price | Open | High | Low | Volume |
18 Wed Sep 2024 | 238.85 | 242.10 | 247.95 | 238.00 | 0.534 times |
17 Tue Sep 2024 | 242.10 | 246.00 | 258.90 | 239.90 | 1.003 times |
16 Mon Sep 2024 | 246.25 | 257.15 | 268.00 | 241.30 | 0.854 times |
13 Fri Sep 2024 | 257.15 | 264.60 | 264.60 | 252.35 | 1.074 times |
12 Thu Sep 2024 | 259.85 | 238.50 | 271.95 | 236.55 | 5.204 times |
11 Wed Sep 2024 | 237.30 | 235.90 | 245.50 | 235.10 | 0.259 times |
10 Tue Sep 2024 | 237.45 | 235.30 | 240.00 | 232.00 | 0.247 times |
09 Mon Sep 2024 | 237.05 | 240.20 | 241.95 | 235.00 | 0.274 times |
06 Fri Sep 2024 | 237.20 | 240.60 | 253.00 | 235.55 | 0.691 times |
05 Thu Sep 2024 | 239.30 | 241.50 | 245.65 | 237.15 | 0.184 times |
My analysis of stock is bearish for shortterm, but stock is semi over sold and there are some chances of seeing a recovery tomorrow. Use 235.6 as stoploss in an intra day buy trade for a target of 243.74. However, stock will show a bearish move below 235.6.
Share price targets for Par Drugs (PAR)
Target Type | Value |
Downside Target | 210.00 |
Downside Target | 220.00 |
Downside Target | 225.00 |
Downside Target | 232.00 |
Upside Target | 246.85 |
Upside Target | 260.00 |
Upside Target | 263.50 |
Upside Target | 268.00 |
Upside Target | 270.00 |
Upside Target | 271.95 |
Upside Target | 282.60 |
Intraday share price targets for Par Drugs (PAR)
Target Type | Value |
Downside Intraday Target | 228.57 |
Downside Intraday Target | 218.28 |
Upside Intraday Target | 258.57 |
Upside Intraday Target | 278.28 |
Upside Intraday Target | 248.28 |
Weekly technical analysis of Par Drugs (PAR)
Date | Weekly Closing Price | Open | High | Low | Volume |
18 Wed Sep 2024 | 238.85 | 257.15 | 268.00 | 238.00 | 0.339 times |
13 Fri Sep 2024 | 257.15 | 240.20 | 271.95 | 232.00 | 4.654 times |
06 Fri Sep 2024 | 237.20 | 259.00 | 260.00 | 235.55 | 0.209 times |
30 Fri Aug 2024 | 253.19 | 244.00 | 263.50 | 225.00 | 7.19 times |
23 Fri Aug 2024 | 236.60 | 235.15 | 246.85 | 234.01 | 0.664 times |
Price has moved down this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Par Drugs (PAR)
Date | Monthly Closing Price | Open | High | Low | Volume |
18 Wed Sep 2024 | 238.85 | 259.00 | 271.95 | 232.00 | 0.871 times |
30 Fri Aug 2024 | 253.19 | 237.00 | 263.50 | 220.00 | 1.05 times |
31 Wed Jul 2024 | 237.19 | 248.50 | 270.00 | 226.87 | 1.163 times |
28 Fri Jun 2024 | 246.81 | 232.80 | 262.44 | 210.00 | 0.984 times |
Scroll below to view daily charts
Price has moved down this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Par Drugs (PAR)
Price action analysis of Par Drugs ( (PAR) ) based on a short term time period is negative, but sellers have recently become active on the stock. This cannot be called a strong downtrend, specially if selected time duration is small
Price action analysis of Par Drugs ( (PAR) ) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Par Drugs ( (PAR) ) based on a short to mid term time period is negative, but sellers have recently become active on the stock. This cannot be called a strong downtrend, specially if selected time duration is small
Price action analysis of Par Drugs ( (PAR) ) based on a mid to longer term time period is neutral. A longer time frame might give a better analysis.
ADX buy sell signal for Par Drugs stock for short term is BUY. Signal strength is Weak and stock is losing momentum.
MACD generated a SELL signal for Par Drugs in short term but the sell signal is initial and weak.
Par Drugs Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are getting stronger in this stock.
Ichimoku cloud is of green color and prices are in or below the green cloud Prices appear to be coming down
CCI has generated a SELL signal for Par Drugs in short term and SELL signal is strong!
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Par Drugs is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 252.04 and Par Drugs (PAR) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Par Drugs (PAR) stock. Volume based technical analysis of Par Drugs (PAR) stock is negative.
Par Drugs Stock has given negative returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Par Drugs ( (PAR) ) based on a short term time period is negative, but sellers have recently become active on the stock. This cannot be called a strong downtrend, specially if selected time duration is small
Price action analysis of Par Drugs ( (PAR) ) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Par Drugs ( (PAR) ) based on a short to mid term time period is negative, but sellers have recently become active on the stock. This cannot be called a strong downtrend, specially if selected time duration is small
Price action analysis of Par Drugs ( (PAR) ) based on a mid to longer term time period is neutral. A longer time frame might give a better analysis.
ADX buy sell signal for Par Drugs stock for short term is BUY. Signal strength is Weak and stock is losing momentum.
MACD generated a SELL signal for Par Drugs in short term but the sell signal is initial and weak.
Par Drugs Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are getting stronger in this stock.
Ichimoku cloud is of green color and prices are in or below the green cloud Prices appear to be coming down
CCI has generated a SELL signal for Par Drugs in short term and SELL signal is strong!
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Par Drugs is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 252.04 and Par Drugs (PAR) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Par Drugs (PAR) stock. Volume based technical analysis of Par Drugs (PAR) stock is negative.
Par Drugs Stock has given negative returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Click here for Par Drugs charts
Click here for further forecast and predictions for tomorrow
Daily charts
COMMODITY Gainers BSE Gainers BSE Losers BSE Scanner CLOSED NEAR HIGH BSE Scanner CLOSED NEAR LOW USA Gainers USA Losers USA Scanner CLOSED NEAR HIGH USA Scanner CLOSED NEAR LOW USA Scanner UPTRENDING USA Scanner DOWNTRENDING
Munafa NEWSTerms of Use Stock Market News! © munafa.org.in2024 All Rights reserved.